Laurus Labs Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Laurus Labs will hold a meeting of the Board of Directors of the Company on 24 July 2026.

Laurus Labs Ltd is up for a third straight session in a row. The stock is quoting at Rs 1475.1, up 2.73% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.73% on the day, quoting at 23927.6. The Sensex is at 76562.32, down 0.69%. Laurus Labs Ltd has added around 8.76% in last one month.

Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has added around 1.53% in last one month and is currently quoting at 24762.9, up 1.17% on the day. The volume in the stock stood at 26.77 lakh shares today, compared to the daily average of 18.03 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 1471.5, up 2.47% on the day. Laurus Labs Ltd is up 120.31% in last one year as compared to a 4.46% fall in NIFTY and a 15.59% fall in the Nifty Pharma index.

The PE of the stock is 104.38 based on TTM earnings ending March 26.

Powered by Capital Market - Live News

Laurus Labs has allotted 3,93,001 equity shares under ESOP on 04 June 2026. The total paid up capital of the Company after the above allotments stands at Rs.1,08,04,99,166/- divided into 54,02,49,583 equity shares of Rs.2/- each.

Laurus Labs Ltd rose for a third straight session today. The stock is quoting at Rs 1389.5, up 1.14% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.07% on the day, quoting at 23930.5. The Sensex is at 75999.31, down 0.01%. Laurus Labs Ltd has added around 27.42% in last one month.

Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has added around 6.68% in last one month and is currently quoting at 24659.2, up 0.19% on the day. The volume in the stock stood at 9.51 lakh shares today, compared to the daily average of 25.19 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 1396.3, up 1.11% on the day. Laurus Labs Ltd is up 127.6% in last one year as compared to a 3.32% fall in NIFTY and a 15.48% fall in the Nifty Pharma index.

The PE of the stock is 100.13 based on TTM earnings ending March 26.

Powered by Capital Market - Live News